Methotrexat Gry (Methotrexate Disodium)

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folate into its active form. This inhibition limits the synthesis of nucleotides required for DNA replication, thereby suppressing the proliferation of immune cells and cancer cells.

The prescribed dose of Methotrexat Gry is individualized by the treating physician based on the specific indication, patient weight, renal and hepatic function, and response to therapy. No universal dosing schedule is provided; the prescriber sets the regimen.

Methotrexat Gry is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal malformations and miscarriage. It is also not recommended for breastfeeding mothers because it can be excreted in breast milk and harm the infant.

To request Methotrexat Gry, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and necessary import documentation.

Methotrexat Gry shares the folate‑antagonist mechanism with drugs like pemetrexed but differs in potency, dosing routes, and approved indications. Compared with non‑folate antimetabolites such as azathioprine, methotrexate generally offers stronger immunosuppressive effects but may require more intensive monitoring for hepatic and hematologic toxicity.

Methotrexat Gry should be stored in a refrigerator at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the product to maintain stability.

The medication is supplied as a sterile injectable solution and is administered by a qualified healthcare professional via intramuscular, intravenous, or intrathecal injection, depending on the clinical indication and treatment protocol.

Serious adverse events include severe bone marrow suppression leading to pancytopenia, hepatotoxicity that can progress to fibrosis or cirrhosis, pulmonary toxicity such as interstitial pneumonitis, acute renal failure, and rare anaphylactic reactions. Prompt monitoring and early detection are essential.

Methotrexat Gry is contraindicated in pregnant women, patients with severe renal or hepatic impairment, those with uncontrolled infections, and individuals with known hypersensitivity to methotrexate or any component of the formulation.